Browse articles from EyeWorld.org related to dry eye. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Dry eye continues to be an important topic because of the many patients impacted and different ways it can present. Two cornea specialists highlighted some of the newer treatment options and how they are handling dry eye in their practice, including how they have updated their approach with experience.
➤ FDA clears device for MGD treatment ➤ Significant investments made in whole-eye transplant research ➤ Enrollment completed early in Phase 3 trial for novel glaucoma drop ➤ Studies make progress with gene and mRNA-based therapies for retinal conditions ➤ ASCRS news and events
➤ Last patient visit in proof-of-concept cell therapy ➤ Phase 2 data for allergic eye inflammation drop published ➤ NDA resubmission to the FDA for topical ocular reproxalap ➤ Positive topline results from Phase 2b suprachoroidal wet AMD therapy ➤ Complimentary access to video journal ➤ Partnership news ➤ ASCRS news and events
➤ Roll-out expanded for presbyopia-correcting IOL ➤ Study: Phase 3 clinical trials evaluate phentolamine ophthalmic solution ➤ AI listening innovation for ophthalmologists ➤ ASCRS news and events
Punctal occlusion remains an important resource to help dry eye patients. Several ophthalmologists shared how they use punctal occlusion in practice, available options, and a new product in this space.
➤ NDA submitted for presbyopia treatment ➤ FDA approves AMD treatment ➤ Primary endpoint achieved in Phase 3 trial of reproxalap for dry eye ➤ Clinical trial results that supported new excimer laser approval published ➤ Company updates on several clinical trials ➤ First patient dosed in Phase 2 trial for intravitreal steroid implant for DME treatment ➤ ASCRS news and events
➤ FDA 510(k) clearance granted to cataract surgery system ➤ Laser for POAG receives CE Mark ➤ Collaboration to develop dry eye treatment ➤ First patients enrolled in Phase 3 wet AMD trial ➤ New open-access textbook on lens power calculations ➤ ASCRS news and events
➤ FDA grants De Novo classification to ocular pressure adjusting pump ➤ Inaugural ‘State of Dry Eye’ survey ➤ Study: potentially higher risk for blinding ocular condition with semaglutide use ➤ Wet AMD treatment implant reintroduced ➤ Acquisition news ➤ ASCRS news and events
➤ Topline results from trial for biologic eye drop for dry eye ➤ First patient dosed in Phase 3 trial evaluating oral non-opioid sedation ➤ First patient dosed in retinitis pigmentosa gene therapy trial ➤ Clinical program for IOP-lowering drug discontinued ➤ ASCRS news and events
➤ 52-week Phase 3 data published for cyclosporine, 0.1% ➤ First patient enrolled in Phase 3 trial assessing new treatment for MGD ➤ Geographic atrophy treatment trial advances to highest dose ➤ New dataset added to support various areas of research and development ➤ ASCRS news and events